Showing 8041-8050 of 20877 results for "".
Overcoming the Challenges of Diabetes: Talking With an 'Amazing Race' Winner
https://reachmd.com/programs/diabetes-discourse/overcoming-the-challenges-of-diabetes-talking-with-an-amazing-race-winner/6420/The management of diabetes is an ongoing challenge for both the healthcare provider and patient in terms of balancing insulin regimens, glucose monitoring, diet and exercise. How does the diabetes educator help to "win the race" for a patient with diabetes? Join host Dr. Steven Edelman and his guestShould I Fire My Doctor? Eleven Essential Elements to Living Well Aware
https://reachmd.com/programs/book-club/should-fire-doctor-eleven-essential-elements-living-well-aware/7841/Dr. Thomas Wright joins Dr. Patricia Sulak, renowned OB/GYN and author of Should I Fire My Doctor? Eleven Essential Elements to Living Well Aware, to discuss the key principles outlined in her book. Should I Fire My Doctor details the self-induced nature of common health problems today and how patieInvestigating SGLT-2 Inhibitors in Diabetes: Considerations & Conversation
https://reachmd.com/programs/diabetes-discourse/investigating-sglt-2-inhibitors-in-diabetes-considerations-and-conversation/12395/Do we know enough yet to safely issue SGLT-2 inhibitors to our patients with diabetes?Improving Diabetes Care with Technology: A Look at Continuous Glucose Monitors
https://reachmd.com/programs/diabetes-discourse/improving-diabetes-care-with-technology-a-look-at-continuous-glucose-monitors/12252/How is technology like continuous glucose monitors impacting the way we care for patients with diabetes?Purging Type 1 Poliovirus: Steps Toward Global Eradication
https://reachmd.com/programs/focus-on-global-medicine/purging-type-1-poliovirus-steps-toward-global-eradication/3946/The World Health Organization (WHO) is working diligently to eliminate Type 1 poliovirus transmission in endemic countries around the world. Although progress has been made using the trivalent oral poliovirus vaccine, eradication remains elusive. Recent studies have examined the efficacy of a monovaAssessing Atypical Diabetes: Detection & Diagnosis
https://reachmd.com/programs/diabetes-discourse/assessing-atypical-diabetes-detection-and-diagnosis/12229/What do we know about atypical diabetes and what can we do to better recognize it?After the Diet: Mindful Integration of Food and Behavior in Diabetes Management
https://reachmd.com/programs/diabetes-discourse/after-the-diet-mindful-integration-of-food-and-behavior-in-diabetes-management/6214/There are many challenges in overall diabetes management relative to a patients' mindful integration of food and behavior. What do healthcare professionals need to know to help their patients with diabetes better manage diet, stress and physical activity? Join guest host Janice Baker, CDE, RD and heCardiac Screening for Asymptomatic Patients With Diabetes
https://reachmd.com/programs/focus-on-diabetes/cardiac-screening-for-asymptomatic-patients-with-diabetes/6095/It is often thought that patients with diabetes have more "silent" heart disease than patients without diabetes: Coronary artery disease is a leading cause of death among these patients. But is screening all asymptomatic patients with diabetes for the condition prudent, or should we exercise cautionStudy Finds Diabetes in the United States Continues to Rise
https://reachmd.com/programs/the-jama-report/study-finds-diabetes-united-states-continues-rise/7696/[Read the Article] Twenty-nine million people in the United States have diabetes. If left untreated, diabetes can cause serious health-related complications. The total estimated cost of diabetes in the United States was $245 billion in 2012, which includes both health care costs and lost productivitFinerenone vs Placebo in Type 1 Diabetes and CKD: Updates From the Phase 3 FINE-ONE Trial From the Kidney Meeting 2025 in Houston
https://reachmd.com/clinical-practice/nephrology/finerenone-vs-placebo-in-type-1-diabetes-and-ckd-updates-from-the-phase-3-fine-one-trial-from-the-kidney-meeting-2025-in-houston/36517/Are you current with the findings from the phase 3 FINE-ONE trial? Join Dr. Heerspink as he summarizes what you need to know about this study.